Invivyd, Inc. (IVVD)
2.47
+0.04
(+1.65%)
USD |
NASDAQ |
Dec 31, 16:00
2.49
+0.02
(+0.81%)
After-Hours: 20:00
Invivyd Free Cash Flow: -80.44M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 9.691M |
| Relmada Therapeutics, Inc. | -39.99M |
| Arcellx, Inc. | -201.18M |
| ADMA Biologics, Inc. | 40.61M |
| Cidara Therapeutics, Inc. | -132.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.25M |
| Cash from Financing (Quarterly) | 58.31M |
| Free Cash Flow Per Share (Quarterly) | -0.0485 |
| Free Cash Flow to Equity (Quarterly) | -7.962M |
| Free Cash Flow to Firm (Quarterly) | -8.25M |
| Free Cash Flow Yield | -24.58% |